# Passage BIO, Inc.: filings

PASG · Nasdaq · CIK 1787297 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pasg.md) · [Financials](/companies/pasg/financials.md) · [Filings](/companies/pasg/filings.md) · [Insiders](/companies/pasg/insiders.md)

## Reports and events: 143 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 163, 8-K 88, 3 30, 10-Q 20, 144 11, SC 13G 11, SC 13D/A 10, SC 13G/A 10, S-8 8, 10-K 6, CORRESP 6, DEF 14A 6, DEFA14A 6, EFFECT 5, SCHEDULE 13D/A 5, 425 4, ARS 4, S-4/A 4, SCHEDULE 13G/A 4, SC 13D 3, SEC STAFF LETTER 3, UPLOAD 3, 424B3 2, 4/A 2, DRS 2, POS AM 2, PRE 14A 2, S-1 2, S-1/A 2, SCHEDULE 13G 2, 3/A 1, 424B1 1, 424B4 1, 424B5 1, 8-A12B 1, CERT 1, D 1, DRS/A 1, DRSLTR 1, FWP 1, POSASR 1, S-1MEF 1, S-3 1, S-3ASR 1, S-4 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-03 | 01:37 ET | [8-K](/filings/0001140361-26-035515.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-26-035515 |
| 2026-08-10 | 11:15 ET | [10-Q](/filings/0001104659-26-093021.md) | Quarterly report, period 2026-06-30 | 0001104659-26-093021 |
| 2026-07-02 | 01:19 ET | [SCHEDULE 13D](/filings/0000902664-26-003000.md) | Ownership report, active investor | 0000902664-26-003000 |
| 2026-06-24 | 20:15 ET | [8-K](/filings/0001104659-26-077306.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-077306 |
| 2026-05-27 | 20:15 ET | [8-K](/filings/0001104659-26-066956.md) | 1.02 Termination of a material agreement | 0001104659-26-066956 |
| 2026-05-26 | 11:15 ET | [8-K](/filings/0001104659-26-065991.md) | 5.07 Shareholder vote results | 0001104659-26-065991 |
| 2026-05-12 | 11:01 ET | [10-Q](/filings/0001104659-26-058987.md) | Quarterly report, period 2026-03-31 | 0001104659-26-058987 |
| 2026-04-28 | 11:00 ET | [8-K](/filings/0001104659-26-049755.md) | 2.05 Exit or disposal costs | 0001104659-26-049755 |
| 2026-04-20 | 11:15 ET | [8-K](/filings/0001104659-26-045219.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-045219 |
| 2026-04-07 | 11:00 ET | [DEF 14A](/filings/0001104659-26-040130.md) | Proxy statement, period 2026-05-19 | 0001104659-26-040130 |
| 2026-03-10 | 11:15 ET | [8-K](/filings/0001104659-26-025550.md) | 1.02 Termination of a material agreement | 0001104659-26-025550 |
| 2026-03-03 | 12:15 ET | [10-K](/filings/0001104659-26-022549.md) | Annual report, period 2025-12-31 | 0001104659-26-022549 |
| 2026-03-03 | 12:00 ET | [8-K](/filings/0001104659-26-022539.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-022539 |
| 2026-01-12 | 12:01 ET | [8-K](/filings/0001104659-26-002696.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002696 |
| 2025-11-10 | 21:31 ET | [10-Q](/filings/0001104659-25-109180.md) | Quarterly report, period 2025-09-30 | 0001104659-25-109180 |
| 2025-11-10 | 21:15 ET | [8-K](/filings/0001104659-25-109158.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-109158 |
| 2025-09-18 | 20:30 ET | [8-K](/filings/0001104659-25-091288.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-091288 |
| 2025-08-12 | 11:15 ET | [10-Q](/filings/0001558370-25-011146.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011146 |
| 2025-08-12 | 11:00 ET | [8-K](/filings/0001558370-25-011143.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-011143 |
| 2025-07-29 | 21:00 ET | [8-K](/filings/0001104659-25-071779.md) | 8.01 Other events | 0001104659-25-071779 |
| 2025-07-24 | 21:44 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000684.md) | Ownership report, active investor, amended | 0000947871-25-000684 |
| 2025-07-21 | 21:28 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000678.md) | Ownership report, active investor, amended | 0000947871-25-000678 |
| 2025-07-14 | 11:01 ET | [8-K](/filings/0001104659-25-067561.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-067561 |
| 2025-07-09 | 00:06 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000657.md) | Ownership report, active investor, amended | 0000947871-25-000657 |
| 2025-06-23 | 11:00 ET | [8-K](/filings/0001104659-25-061371.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-061371 |
| 2025-05-30 | 20:25 ET | [8-K](/filings/0001104659-25-054907.md) | 5.07 Shareholder vote results | 0001104659-25-054907 |
| 2025-05-13 | 11:15 ET | [10-Q](/filings/0001558370-25-007489.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007489 |
| 2025-05-13 | 11:00 ET | [8-K](/filings/0001558370-25-007487.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-007487 |
| 2025-04-25 | 23:48 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000425.md) | Ownership report, active investor, amended | 0000947871-25-000425 |
| 2025-04-16 | 11:00 ET | [DEF 14A](/filings/0001558370-25-004877.md) | Proxy statement, period 2025-05-28 | 0001558370-25-004877 |
| 2025-03-04 | 12:15 ET | [10-K](/filings/0001558370-25-002101.md) | Annual report, period 2024-12-31 | 0001558370-25-002101 |
| 2025-03-04 | 12:00 ET | [8-K](/filings/0001558370-25-002093.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-002093 |
| 2025-01-31 | 21:06 ET | [8-K](/filings/0001104659-25-008100.md) | 3.01 Delisting notice | 0001104659-25-008100 |
| 2025-01-10 | 12:00 ET | [8-K](/filings/0001104659-25-002278.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 2.06 Material impairments; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-002278 |
| 2024-12-26 | 21:31 ET | [SCHEDULE 13D/A](/filings/0000947871-24-001036.md) | Ownership report, active investor, amended | 0000947871-24-001036 |
| 2024-11-13 | 12:15 ET | [10-Q](/filings/0001558370-24-015431.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015431 |
| 2024-11-13 | 12:00 ET | [8-K](/filings/0001558370-24-015429.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-015429 |
| 2024-10-24 | 11:00 ET | [8-K](/filings/0001558370-24-013563.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-013563 |
| 2024-09-16 | 11:00 ET | [8-K](/filings/0001558370-24-012793.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-012793 |
| 2024-09-10 | 11:00 ET | [8-K](/filings/0001104659-24-098371.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-098371 |
| 2024-09-06 | 20:15 ET | [8-K](/filings/0001558370-24-012654.md) | 2.06 Material impairments | 0001558370-24-012654 |
| 2024-08-09 | 23:06 ET | [SC 13D/A](/filings/0001193125-24-198056.md) | Ownership report, active investor, amended | 0001193125-24-198056 |
| 2024-08-08 | 11:15 ET | [10-Q](/filings/0001558370-24-011463.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011463 |
| 2024-08-08 | 11:00 ET | [8-K](/filings/0001558370-24-011459.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-011459 |
| 2024-08-02 | 20:06 ET | [8-K](/filings/0001104659-24-085360.md) | 3.01 Delisting notice | 0001104659-24-085360 |
| 2024-08-01 | 11:00 ET | [8-K](/filings/0001104659-24-084615.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-084615 |
| 2024-07-16 | 11:01 ET | [8-K](/filings/0001558370-24-009826.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-009826 |
| 2024-05-29 | 20:35 ET | [SC 13D/A](/filings/0001193125-24-149241.md) | Ownership report, active investor, amended | 0001193125-24-149241 |
| 2024-05-22 | 20:03 ET | [8-K](/filings/0001104659-24-064243.md) | 5.07 Shareholder vote results | 0001104659-24-064243 |
| 2024-05-14 | 11:15 ET | [10-Q](/filings/0001558370-24-008058.md) | Quarterly report, period 2024-03-31 | 0001558370-24-008058 |

Page 1 of 3. [Older](/companies/pasg/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.